HOBIT – Hyperbaric Oxygen Brain Injury Treatment Trial

HCMC is part of a national research study that will see if high dose oxygen given under pressure can help people age 16-65 with severe traumatic brain injury. This treatment is also known as hyperbaric oxygen treatment. The goal of the study is to identify the best way to deliver high dose oxygen under pressure so that severe traumatic brain injury patients can recover with less disability. Because the experimental treatment must be given quickly, patients 16 to 65 years old may be enrolled without informed consent. All patients will receive standard care for their traumatic brain injury.  For more information or to learn how to opt out, visit hobittrial.org.